Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers

Duruisseaux, M; Rouquette, I; Adam, J; Cortot, A; Cazes, A; Gibault, L; Damotte, D; Lantuejoul, S

Lantuejoul, S (reprint author), Ctr Lutte Canc Leon Berard, Dept Biopathol, MESOPATH, 28 Rue Laennec, F-69008 Lyon, France.

ANNALES DE PATHOLOGIE, 2017; 37 (1): 61

Abstract

Tumoral immune environment is a major component of cancer. Its composition and its organization represent a reproducible characteristic of tumors and ......

Full Text Link